Review on Alzheimer's Diseases

Authors

  • Kumari Meena*, Himani Tiwari, Kaushal Kishor Chandrul Author

Keywords:

Alzheimer's Diseases , cholinesterase inhibitors , behavioural disturbance , etiology , epidemiology, antioxidant , anti- inflammatory agents , estrogen replacement therapy.

Abstract

Alzheimer's Diseases are one of the most serious brain condition affecting senior peoples. Improved cognitive disorders therapy, better behaviour and clinical diagnostic standard are recent breakthrough. Placebocontrolled, double —blind, Randomised, parallel group studies evaluating performance -based assessment of cognitive function, activities of daily living and behaviour have been used to clinically evaluate symptomatic treatment that focuses on cholinergic therapy. Patient of Alzheimer's disease are advised to use cholinesterase inhibitors,such as ntamine and tacrine ,to address cognitive impairment. Antipsychotics, anxiolytics, antidepressants, mood stabilizer and hypnotics are used in treatment of behavioural disturbance. Evaluation in research and treatment of patients of Alzheimer's disease includes: Applying functional brain imaging techniques and evaluation of treatment efficacy. Development of new classes of medications works on different neurotransmitter systems, for the treatment of cognitive deficits and behavioural disturbance.

Downloads

Published

2024-06-30

Issue

Section

Articles

How to Cite

Review on Alzheimer’s Diseases. (2024). International Journal of Pharmacy and Life Sciences, 15(6), 12-15. http://ijplsjournal.com/index.php/ijpls/article/view/86

Similar Articles

11-20 of 454

You may also start an advanced similarity search for this article.